A
This test is used to evaluate renal disease and other chronic diseases.
This test is used to detect and monitor liver and/or bone disease.
| Optimal Range: |
25-150 IU/L |
This test is used to identify liver disease and to distinguish between
the liver and red blood cell hemolysis as the source of jaundice.
This test is used to evaluate the possibility of coronary occlusive
heart disease or liver disease.
This test is used to evaluate survival rate or risk factors for patients
with myocardial infarction and peripheral vascular diseases. APO A-1
deficiency states include Tangier disease, HDL deficiency, and hypoalpha-lipoprotein
anemia. The apolipoprotein levels may be a better indicator of atherogenic
risks than high-density lipoprotein (HDL), low-density lipoprotein
(LDL), and very-low-density lipoprotein (VLDL).
Normal Ranges : |
| Male: |
110-180 mg/dL |
| Female: |
110-205 mg/dL |
Optimal Ranges: |
| Male: |
130-180 mg/dL |
| Female: |
130-205 mg/dL |
B TOP
This test is used to evaluate liver function.
Normal Ranges : |
| Total Bilirubin: |
0.1-1.2 mg/dL |
| Indirect Bilirubin: |
0.2-0.8 mg/dL |
| Direct Bilirubin: |
0.1-0.3 mg/dL |
This test is used to measure liver function and to indirectly assess renal function
and glomerular filtration rate.
| Normal Range : |
5-26 mg/dL |
This test is used to diagnose impaired renal function. With creatinine, BUN is
used to monitor patients on dialysis. (Calculation)
| Normal Range : |
12:1 to 20:1 |
C TOP
The CA 15-3 antigens are tumor-associated serum markers, most specifically
for breast tissue, available for monitoring various types of malignancies,
evaluating response to therapy, and as possible indicators of recurrence.
Normal Range : |
| CA 15-3: |
0.0-31.3 U/mL |
Cancer Antigen (CA) 125
This test is a tumor marker for monitoring disease progression in ovarian cancer.
It is most useful in monitoring progression or recurrence in cases of known ovarian
carcinoma.
Normal Range : |
| CA 125: |
0-35 U/mL |
This test is used to diagnose systemic candidiasis. Candidiasis normally occurs
in the mouth, vagina, or gastrointestinal tract. This test is qualitative and
if candida antibodies are found, you have had or now have a candida infection.
This test is used to assist in the evaluation of the pH and electrolytes
status.
| Normal Range : |
20-32 mmol/L |
This test is used to evaluate parathyroid function and calcium metabolism.
| Normal Range : |
8.5-10.6 mg/dL |
This test is used to monitor gastrointestinal, pancreatic, liver, and colorectal
malignancies. This test may also be positive in patients with non-neoplastic
disease, inflammatory disease of the bowel, cirrhosis, and autoimmune conditions.
Normal Range : |
| CA 19-9: |
0-37 U/mL |
This tumor marker is used to determine the extent of disease and its prognosis
in cancer patients (especially gastrointestinal or breast cancers). It can also
be used to monitor the disease and its treatment.
Normal Ranges : |
| Nonsmoker: |
0-3.0 ng/mL |
| Smoker: |
0-5.0 ng/mL |
This is a series of tests of the peripheral blood which provides a variety of
information about the blood components. Red Blood Cell Count
Normal Ranges : |
| Male: |
4.1-5.6 million/mm3 |
| Female: |
3.8-5.10 million/mm3 |
This test is used to determine the ratio of CD4-helper cells to CD8-suppressor
cells. A progressive depletion of CD4 T lymphocytes is associated with the increased
likelihood of clinical complications from AIDS. These test results can indicate
if an AIDS patient is at risk for developing opportunistic infections.
This panel is a comprehensive blood evaluation including the following 35 tests:
Glucose Fasting . This test directly measures glucose levels and is commonly
used in the evaluation of diabetes.
| Normal Range : |
65-109 mg/dL |
| Optimal Range: |
70-100 mg/dL |
This test is used to determine the risk of developing coronary heart disease
(CHD) and hyperlipidemias.
| Normal Range : |
100-199 mg/dL |
| Optimal Range: |
180-200 mg/dL |
This is a renal function test used to estimate glomerular filtration rate and
to follow progression of renal disease.
Normal Ranges : |
| Male: |
0.5-1.5 mg/dL |
| Female: |
0.5-1.1 mg/dL |
This test by itself does not provide adequate information. However, as part of
a multiphasic testing for electrolytes, it can give an indication of acid-base
balance and hydration status.
| Normal Range : |
96-109 mmol/L |
This test is used to evaluate diabetics and monitor insulinoma.
Normal Ranges : |
| Fasting: |
0.9-4.0 ng/mL |
| 1 hour after glucose load: |
5-12 ng/mL |
This test is to measure adrenal function. It is used to diagnose adreno-cortical
insufficiency/hypersecretion and Cushing's syndrome and is also useful in detecting
malfunction of the hypothalamic axis.
Normal Ranges : |
| a.m.: |
4.3-22.4 mcg/dL |
| p.m.: |
3.1-16.7 mcg/dL |
This test is used to assess risk of cardiovascular and peripheral vascular disease.
Normal Ranges : |
Relative Risks-Male |
| CRP (mg/L) |
Future MI |
Future Stroke |
| > 2.11 |
2.9 |
1.9 |
| 1.15-2.10 |
2.6 |
1.9 |
| 0.56-1.14 |
1.7 |
1.7 |
| < 0.55 |
1.0 |
1.0 |
Relative Risks-Female |
| CRP (mg/L) |
Future MI or Stroke |
| > 7.30 |
5.5 |
| 3.80-7.30.1.1.1 |
3.5 |
| 1.50-3.70.1.1.1.1 |
2.7 |
| < 1.50 |
1.0 |
| Optimal Range: |
As low as possible. |
These tests are used to find the source of chronic inflammation, after a high
CRP reading or the persistence of any chronic inflammatory condition. These tests
can be ordered as a panel or individually. Pro-Inflammatory Cytokines
Normal Ranges
(All Adults): |
| Interleukin-1B (IL-1B) |
0-150 pg/mL |
| Interleukin-6 (IL-6) |
2-29 pg/mL |
| Interleukin-8 (IL-8) |
10-80 pg/mL |
Tumor Necrosis Factor-alpha (TNF-a)
| Normal Range (All
Adults): |
0-25 pg/mL |
D TOP
This test is used to determine female infertility, amenorrhea,
or hirsutism and to aid in the evaluation of excess androgen/adrenocortical
disease including congenital adrenal hyperplasia and adrenal tumors.
Normal Ranges : |
Male |
| 18-30 years: |
125-619 mcg/dL |
| 31-50 years: |
59-452 mcg/dL |
| 51-60 years: |
20-413 mcg/dL |
| 61-83 years: |
10-285 mcg/dL |
| Optimal Range: |
400-500 mcg/dL |
Female |
| 19-30 years: |
29-781 mcg/dL |
| 31-50 years: |
12-379 mcg/dL |
| Postmenopausal: |
30-260 mcg/dL |
| Optimal Range: |
350-430 mcg/dL |
This test measures serum concentrations of dihydrotestosterone
and is closely related to those of testosterone, but are lower,
and may indicate hypergonadism or hirsutism.
Normal Ranges : |
| Male: |
30-85 mg/dL |
| Female: |
4-22 mg/dL |
Optimal Ranges: |
| Male: |
30-50 mg/dL |
E TOP
This test is used to diagnose a suspected EBV infection (infectious
mononucleosis, IM).
Normal Range : |
| Titers < 1:10 are nondiagnostic. |
| Titers of 1:10 to 1:60 indicate infection at an undetermined
time. |
| Titers of > 1:320 suggest active infection. |
Fourfold increase in titer in paired sera drawn 10-14 days apart
is usually indicative of an acute infection. ESR Westergen Sedimentation
Rate (ESR, Sed Rate Test)
The ESR is a nonspecific test used to detect illness associated with acute and
chronic infection, inflammation (collagen-vascular diseases), advanced neoplasm,
and tissue necrosis or infarction.
Normal Range ;
Westergren Method: |
| Male: |
up to 15 mm/hr |
| Female: |
up to 20 mm/hr |
Estradiol
This test is used to assess hypothalamic and pituitary functions, menopausal
status, and sexual maturity. In males it is helpful in the assessment of gynecomastia
or feminization syndromes.
| Normal Ranges : |
Serum |
| Adult Male: |
3-70 pg/mL |
Optimal Range: |
10-30 pg/mL |
| Adult Female: |
|
|
|
| Follicular phase: |
9-175 pg/mL |
|
|
| Midcycle peak: |
150-750 pg/mL |
|
|
| Luteal phase: |
44-196 pg/mL |
|
|
| Postmenopausal: |
> 20 g/mL |
|
|
This test provides an objective assessment of placental function and fetal normality
in high-risk pregnancies. Estriol is the major estrogen in the pregnant female.
| Normal Range for
Male or Nonpregnant Female: |
< 2.0 mg/dL |
Estrogen measurements are used to evaluate sexual maturity, menstrual problems,
and fertility problems in females. This test is also used in the evaluation of
males with gynecomastia or feminization syndromes. In pregnant women, it is used
to indicate fetal-placental health. In patients with estrogen-producing tumors,
it can be used as a tumor marker.
Normal Ranges : |
| Male: |
12-72 mg/dL |
| Optimal Range: |
12-34 mg/dL |
Female: |
| Follicular phase: |
37-138 mg/dL |
| Midcycle peak: |
60-229 mg/dL |
| Luteal phase: |
50-114 mg/dL |
This test is used to evaluate postmenopausal bleeding due to peripheral conversion
of androgenic steroids. Increased estrone levels may be associated with increased
levels of circulating androgens and their subsequent peripheral conversion.
Normal Ranges : |
| Male: |
12-72 pg/mL |
Female: |
| Follicular phase: |
37-138 mg/dL |
| Midcycle peak: |
60-229 mg/dL |
| Luteal phase: |
50-114 mg/dL |
Female Panel
Chem Panel, CBC, Free Testosterone, DHEA-S, Estradiol, Progesterone, Homocysteine,
Cardiac CRP Ferritin
This test is used to evaluate iron reserves in the body and to determine iron
deficiency anemia or iron overload.
Normal Ranges : |
| Male: |
22-322 ng/mL |
| Female: |
10-291 ng/mL |
| Optimal Range: |
50-150 ng/mL |
F TOP
This test is used primarily for detecting suspected bleeding disorders
or excessive amounts that could contribute to abnormal clotting.
| Normal Range Adult: |
200-400 mg/dL |
| Optimal Range: |
200-300mg/dL |
| Critical Value: |
Values of < 100 mg/dL can be associated with spontaneous
bleeding. |
| High Value: |
> 400 mg/dL can cause spontaneous clotting. |
This test is used in the determination of menopause and is integral
in the evaluation of suspected gonadal failure.
| Normal Ranges : |
FSH |
| Adult Male: > 15 yrs: |
1.4-18.1 mIU/mL |
| Optimal Range: |
1.4-14 mIU/mL |
| Female: |
|
| Follicular phase: |
2.5-10.2 mIU/mL |
| Ovulatory peak: |
3.4-33.4 mIU/mL |
| Luteal phase: |
1.5-9.1 mIU/mL |
| Postmenopausal phase: |
23.0-116.3 mIU/mL |
| Normal Ranges : |
LH |
| Adult Male: |
|
| 20-70 years: |
0.5-9.3 mIU/mL |
| > 70 years: |
3.1-34.6 mIU/mL |
| Optimal Range: |
0.5-9.3 mIU/mL |
| Female: |
|
| 20-70 years: |
0.0-76.3 mIU/mL |
| > 70 years: |
5.0-52.3 mIU/mL |
| Follicular phase: |
1.9-12.5 mIU/mL |
| Ovulatory peak: |
8.7-76.3 mIU/mL |
| Luteal phase: |
0.5-16.9 mIU/mL |
| Postmenopausal phase: |
5.0-52.3 mIU/mL |
G
This test is a sensitive indicator of hepatobiliary disease (obstructive
jaundice, intrahepatic cholestasis, pancreatitis). It is also used
as an indicator of chronic and heavy alcohol abuse.
| Normal Range Male
and Female: |
0-65 IU/L |
H TOP
This test is used as a tumor marker for certain cancers. Heavy
Metals Profile I, Blood
This test is used to monitor exposure to arsenic, lead, and mercury.
| Optimal Range: |
As low as possible |
This test measures alpha lipoprotein and is used to predict heart
disease.
| Normal Range : |
35-150 mg/dL |
| Optimal Range: |
55-150 mg/dL |
Normal Ranges : |
| Male: |
12.5-17.0 g/dL |
| Female: |
11.5-15.0 g/dL |
| Optimal Range: |
Upper end of normal range |
Normal Ranges : |
| Male: |
36-50% |
| Female: |
34 - 44% |
| Optimal Range: |
Upper end of normal range |
This test is used as an aid in the diagnosis of H. pylori infection and to determine
the cause of chronic type B gastritis, and ulcers of the stomach or duodenum.
H. pylori is the causative agent of Type B active chronic gastritis; there may
be evidence to link H. pylori to duodenal ulcer disease as well. The presence
of IgG and IgA antibodies has been observed in 81-100% of patients with gastritis
but in only 25% of patients without histological evidence of H. pylori . Testing
for IgM is not helpful. Hemoglobin A1C
This test is most frequently used to assess glucose control in insulin-dependent
diabetic patients whose glucose levels are very labile.
| Normal Range Adult: |
4.5-5.7% |
This test is used as a comprehensive panel for detecting markers for HAV, HBV,
or HCV infections and is used for all stages of infection.
| Normal Range : |
Negative or Positive |
Hepatitis B Surface Antibody, Qualitative This test is useful for evaluation
of possible immunity in individuals who are at increased risk for exposure to
hepatitis B.
| Normal Range : |
Negative or Positive |
Hepatitis C Virus Antibody This test is used to assess exposure to hepatitis
C virus infection.
| Normal Range : |
Negative or Positive |
Homocysteine
Homocysteine has been shown to be an independent risk factor for the premature
development of coronary artery disease and thrombosis. This test is intended
for use in screening patients who may be at risk for heart disease and stroke.
| Normal : |
5-15 micromol/L |
| Desirable: |
< 7.2 micromol/L |
| Hyperhomocysteinemia |
| Borderline: |
12-15 micromol/L |
| Moderate: |
> 15-30 micromol/L |
| Intermediate: |
> 30-100 micromol/L |
| Severe: |
> 100 micromol/L |
Studies have shown that even moderate levels of homocysteine pose an increased
risk for arteriosclerosis compared with the lowest 20th percentile (< 7.2
pmol/L) of population controls. Insulin Fasting
This test is used for insulin measurement in the evaluation of patients with
fasting hypoglycemia or hyperglycemia. High fasting insulin is a sign of insulin
resistance and the start of Type-II diabetes or syndrome X.
| Normal Range Adult: |
0-22 mcIU/mL |
| Optimal Range: |
As low as possible, ideally under 5 mcIU/mL |
I TOP
This test is used in the diagnosis of anemia. TIB levels are often
used to monitor the course of patients receiving hyperalimentation.
Normal Ranges : |
| Male: |
40-180mg/dL |
| Female: |
50-170 mg/dL |
| Optimal Range: |
40-100 mg/dL |
| TIBC: |
250-420 mg/dL |
This test is used to evaluate many diseases including iron deficiency
anemia and hemochromatosis.
Normal Ranges : |
| Male: |
40-155 mg/dL |
| Female: |
35-155 mg/dL |
| Optimal Range: |
40-100 mg/dL |
J
TOP
No Test Available
K TOP
No Test Available
L TOP
This test measures the intracellular enzyme LDH which, when present
in the blood, supports the diagnosis of injury or disease.
| Normal Range : |
100-250 IU/L |
This test measures beta lipoproteins and is also used to predict
heart disease.
| Normal Range : |
0-129 mg/dL |
| Optimal Range: |
< 100 mg/dL |
This test is used to diagnose pancreatitis or inflammatory bowel
disease. An injured or diseased pancreas will produce abnormal
amounts of this enzyme.
This test is used to measure excess small dense lipoprotein which
is a strong indicator for premature coronary disease and atherosclerotic
vascular disease and is associated with increased risk of cardiac
death in patients with acute coronary syndromes and coronary bypass
procedures.
| Normal Range : |
0-30 mg/dL |
| Desirable: |
< 20mg/dL |
| Borderline High Risk: |
20-30 mg/dL |
| High Risk: |
31-50 mg/dL |
| Very High Risk: |
> 50 mg/dL |
M TOP
Chem Panel, CBC, Free Testosterone, DHEA-S, PSA, Estradiol, Homocysteine,
Cardiac CRP MHMP
Male Panel + Total Testosterone, Progesterone, FSH & LH, and TSH. Parathyroid
Hormone (PTH), Intact
This test is used in diagnosing parathyroid disease, diagnosing and monitoring
other diseases of calcium homeostasis, and for monitoring patients undergoing
renal dialysis.
| Normal Range Adults
older than 20 years: |
12-72 pg/mL |
N TOP
No Test Available
O TOP
No Test Available
P TOP
This test is used to measure serum phosphorus levels. An imbalance
could indicate the possibility of any number of conditions.
| Normal Range : |
2.5-4.5 mg/dL 12-60 years |
| Male: |
2.3-3.7 mg/dL > 60 years |
| Female: |
2.8-4.1 mg/dL > 60 years |
This test is used to assist in the diagnosis of many diseases that
affect blood proteins as a whole or one single fraction of protein.
Normal Ranges : |
| Total Protein: |
6.0-8.5 grams/dL |
| Albumin: |
3.5-5.5 grams/dL |
| Globulin: |
1.5-4.5 grams/dL |
This routine test is used to evaluate and monitor electrolyte balance and is
especially important for cardiac patients.
| Normal Range : |
3.5-5.5 mEq/L |
This test is used to determine ovarian failure, hirsutism, adrenal carcinoma,
and Cushing's syndrome.
Normal Ranges : |
| Male: |
10-200 ng/dL |
| Female: |
10-230 ng/dL |
| Optimal Range: |
100-170 ng/dL |
This test is used to establish the presence of a functional corpeus luteum or
luteal cell function, confirm body temperature for occurrence of ovulation, obtain
indication of day of ovulation, evaluate the functional state of corpeus luteum
in infertile patients, assess placental function during pregnancy, and evaluate
ovarian function.
Normal Ranges : |
| Male (ng/mL): |
< 0.3-1.2 |
Female: |
| Follicular: |
0.2-1.4 |
| Luteal: |
3.3-25.6 |
| Midluteal: |
4.4-28.0 |
| Postmenopausal: |
0.0-0.7 |
This test is used to assess inappropriate lactation and is also useful in the
detection of prolactin-secreting pituitary tumors. Elevated prolactin is associated
with anovulation and amenorrhea. Prolactin can also be elevated in hypothyroid
when TSH is high. Some studies indicate that elevated prolactin may promote breast
and prostate cancer growth.
Normal Ranges : |
| Male: |
2.1-17.7 ng/mL |
| Optimal Range: |
2.1-5 ng/mL |
| Female: |
2.8-29.2 ng/mL |
| Optimal Range: |
2.8-7 ng/mL |
| Nonpregnant: |
2.8-29.2 ng/mL |
| Pregnant: |
9.7-208.5 ng/mL |
| Postmenopausal: |
1.8-20.3 ng/mL |
Prostate-Specific Antigen (PSA)
PSA is produced by normal, hyperplastic, and cancerous prostatic tissue. Serum
PSA has been found to be the most sensitive marker for monitoring patients with
prostate cancer and to enhance efficacy in monitoring progression of disease
and response to therapy.
| Normal Findings: |
0-4.0 ng/mL |
| Optimal Range: |
0-2.5 ng/mL |
This test is used to measure the percentage of free PSA relative to the amount
of total PSA. This helps determine the probability of prostate cancer. The lower
the percentage of free PSA, the higher the possibility of prostate cancer. The
percentage in the two age groups is the percent with cancer for that percent
of free PSA.
Normal Findings: 0-4.0 ng/mL |
| Free PSA |
50-64 Years |
65-75 Years |
| 0.00%-10.00% |
56% |
55% |
| 10.01%-15.00% |
24% |
35% |
| 15.01%-20.00% |
17% |
23% |
| 20.01%-25.00% |
10% |
20% |
| > 25% |
5% |
9% |
Q TOP
No Test Available
R TOP
Mean Corpuscular Volume .
Mean Corpuscular Hemoglobin
Mean Corpuscular Hemoglobin Concentration
| Normal Range : |
32-36 g/dL |
Red Blood Cell Distribution of Width
| Normal Range : |
11.7%-15.0% |
White Blood Cell Count
| Normal Range : |
4000-10,500/mm3 |
| Critical Values: |
< 2500 or > 30,000/mm3 |
Differential Count
Normal Range Reference
Interval: |
| Polyneutrophils: |
4000-7400/mm3 1.8-7.8 × 10-3/mcL |
| Lymphocytes: |
1400-4600/mm3 0.7-4.5 × 10-3/mcL |
| Monocytes: |
400-300/mm3 0.1-1.0 × 10-3/mcL |
| Eosinophils: |
0-700/mm3 0.0-0.4 × 10-3/mcL |
| Basophils: |
0-300/mm3 0.0-0.2 × 10-3/mcL |
Platelet Count
| Normal Range : |
140-415 × 10-3/mcL |
| Critical Values: |
< 50,000 or > 1 million/mm3 |
This test is useful in evaluating thyroid function and metabolism
and to evaluate euthyroid sick patients with low T3 concentrations.
| Normal Range : |
90-350 pg/mL |
This test is used in the differential diagnosis and prognosis of
arthritic disorders.
| Normal Range --Negative: |
< 10.0 IU/mL |
S TOP
This test is used to monitor selenium deficiency and occupational
exposure. Because selenium is a very important supplement for life
extension, optimal levels are in the upper half of normal range.
| Reference Interval Environmental Exposure: |
79-326 mcg/L |
| Normal Range : |
46-143 mcg/L |
This test is used to monitor SHBG levels that are under the positive
control of estrogens and thyroid hormones and suppressed by androgens.
Decreased levels are found in hirsutism, virilism, obese postmenopausal
women, and women with diffuse hair loss. Increased levels are present
in hyperthyroidism, testicular feminization, cirrhosis, male hypogonadism,
pregnancy, prepubertal children, and in women using oral contraceptives.
Normal Ranges : |
| Adult Male: |
13-71 nmol/L |
| Female: |
1-114 nmol/L |
Optimal Range:
|
Lower part of normal range is
desirable for healthy people. |
This is a test for total estrogens, progesterone, and free testosterone.
Somatomedin-C (IGF-l)
This test is a screening test to identify patients with growth hormone deficiency,
pituitary insufficiency, and acromegaly.
Normal Findings: |
| Age (years) |
Male (ng/mL) |
Female (ng/mL) |
| 16-24 |
182-780 |
182-780 |
| 25-39 |
114-492 |
114-492 |
| 40-54 |
90-360 |
90-360 |
| > 55 |
71-290 |
71-290 |
This routine test is used to evaluate and monitor fluid and electrolyte balance
and therapy.
| Normal Range : |
135-148 mEq/L |
T TOP
This is a thyroid function test for the diagnosis of hypothyroidism
or hyperthyroidism.
| Normal Range : |
|
| Adult Male and Female: |
24-39% |
This test is used to evaluate hirsutism and masculinization in
women; to evaluate testicular function in clinical states where
the testosterone binding proteins may be altered (obesity, cirrhosis,
thyroid disorders). LabCorp. Reference Values
Male: |
Female: |
| 20-29 years |
9.3-26.5 pg/mL |
20-59 years |
0.0-2.2 pg/mL |
| 30-39 years |
8.7-25.1 pg/mL |
> 60 years |
0.0-1.8 pg/mL |
| 40-49 years |
6.8-21.5 pg/mL |
|
|
| 50-59 years |
7.2-24.0 pg/mL |
|
|
| 60+ years |
6.6-18.1 pg/mL |
|
|
| Optimal Range: |
15-22 pg/mL for aging men without prostate
cancer. |
Quest Diagnostics Reference Values
| Adult Male (20-60+ years): |
1.0-2.7% |
50-210 pg/mL |
| Adult Females: |
0.5-1.8% |
1.0-8.5 pg/mL (premenopausal) |
| |
0.8-1.9% |
0.6-6.7 pg/mL (postmenopausal) |
| Optimal Range: |
150-210 pg/mL for aging men without prostate
cancer. |
This test is used to evaluate hirsutism and masculinization in
women and to evaluate testicular function in clinical states where
the testosterone binding proteins may be altered (obesity, cirrhosis,
thyroid disorders). Testosterone, Total
This test is used to evaluate gonadal and adrenal function. It is helpful in
diagnosing hypogonadism, hypo-pituitarism, Klinefelter's syndrome, and impotence
in males and hirsutism, anovulation, amennorrhea, and virilism in females. LabCorp.
Reference Values
Normal Ranges : |
| Male: |
241-827 ng/dL, |
| (Optimal Range: |
500-827 ng/dL) |
| Female: |
14-76 ng/dL |
Quest Diagnostics Reference Values
| Adult Males: |
|
| Normal Range : |
260-1000 ng/dL |
| Optimal Range: |
500-1000 ng/dL (no prostate cancer) |
| Adult Females: |
|
| Premenopausal: |
15-70 ng/dL |
| Postmenopausal: |
5-51 ng/dL |
This test is used to detect and confirm autoimmune thyroiditis and Hashimoto's
thyroiditis.
| Normal Range : |
< 5 mcIU/mL |
This is a function test for thyroid disease to differentiate between primary
and secondary hypothyroidism. Some doctors believe that any TSH levels more than
2.0 should be considered suspect for subclinical hypothyroidism if symptoms are
present.
| Normal Range : |
0.35-5.50 mcIU/mL |
| Optimal Range: |
Under 2.1 mcIU/mL |
This is one of the first tests done in assessing thyroid function. It is used
to diagnose thyroid function and to monitor replacement and suppressive therapy.
| Normal Range Adults: |
4.5-12.0 mcg/dL |
This test is used to evaluate thyroid function in patients who may have protein
abnormalities that could affect total T4 levels. It is also used to diagnose
thyroid function and monitor replacement and suppressive therapy.
| Normal Range : |
0.70-1.53 ng/dL |
This is a test for thyroid function used particularly in the diagnosis of T3
thyrotoxicosis and hyperthyroidism.
| Normal Range : |
60-181 ng/mL |
This test is used to evaluate thyroid function and access abnormal binding protein
disorders.
| Normal Range Adults: |
260-480 pg/mL |
This test is used to identify the risk of developing coronary heart disease or
when disorders in fat metabolism are suspected.
| Normal Range : |
0-199 mg/dL |
| Optimal Range: |
40-100 mg/dL |
This test is used to detect cardiac injury, predict mortality in unstable cases
of angina, and serve as a marker for perioperative myocardial infarction.
This test is used to determine the risk for coronary heart disease.
| Normal Range : |
5:1 or less |
| Optimal Range: |
3:1 or less |
UTOP
This test is used in the evaluation of gout or recurrent urinary calculus.
Normal Ranges : |
| Male: |
2.4-8.2 mg/dL |
| Female: |
2.0-6.6 mg/dL |
| Optimal Range: |
3-7 mg/dL |
This test is used to detect abnormalities of urine and diagnose and manage renal
disease and metabolic disease, urinary tract infection and neoplasm, systemic
diseases, and inflammatory or neoplastic disease. Vitamin B12 & Folate
This test measures the amount of vitamin B12 and folic acid in the blood. It
is used to evaluate malnourished patients, evaluate macrocytic/megaloblastic
anemia, and diagnose congenital absence of transcobalamin II or cobalophilin.
Normal Ranges : |
| B12: |
211-911 pg/mL |
| Folic Acid: |
3-20 ng/mL |
V TOP
No Test Available
W TOP
No Test Available
X TOP
No Test Available
Y TOP
No Test Available
Z TOP
|
|
